Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Companion Diagnostics Market 

5.1. COVID-19 Landscape: Companion Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Companion Diagnostics Market, By Indication

8.1. Companion Diagnostics Market, by Indication, 2023-2032

8.1.1. Cancer

8.1.1.1. Market Revenue and Forecast (2021-2032)

8.1.2. Neurological Disorders

8.1.2.1. Market Revenue and Forecast (2021-2032)

8.1.3. Cardiovascular Diseases

8.1.3.1. Market Revenue and Forecast (2021-2032)

8.1.4. Infectious Diseases

8.1.4.1. Market Revenue and Forecast (2021-2032)

8.1.5. Other Indications

8.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Companion Diagnostics Market, By Product & Service

9.1. Companion Diagnostics Market, by Product & Service, 2023-2032

9.1.1. Assays, Kits & Reagents

9.1.1.1. Market Revenue and Forecast (2021-2032)

9.1.2. Software & Services

9.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Companion Diagnostics Market, By Technology 

10.1. Companion Diagnostics Market, by Technology, 2023-2032

10.1.1. Polymerase Chain Reaction

10.1.1.1. Market Revenue and Forecast (2021-2032)

10.1.2. Next-generation Sequencing

10.1.2.1. Market Revenue and Forecast (2021-2032)

10.1.3. In Situ Hybridization

10.1.3.1. Market Revenue and Forecast (2021-2032)

10.1.4. Immunohistochemistry

10.1.4.1. Market Revenue and Forecast (2021-2032)

10.1.5. Other

10.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Companion Diagnostics Market, By Indication

11.1. Companion Diagnostics Market, by Indication, 2023-2032

11.1.1. Oncology

11.1.1.1. Market Revenue and Forecast (2021-2032)

11.1.2. Neurology

11.1.2.1. Market Revenue and Forecast (2021-2032)

11.1.3. Infectious Diseases

11.1.3.1. Market Revenue and Forecast (2021-2032)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2032)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Companion Diagnostics Market, By End-User

12.1. Companion Diagnostics Market, by End-User, 2023-2032

12.1.1. Pharmaceutical & Biopharmaceutical Companies

12.1.1.1. Market Revenue and Forecast (2021-2032)

12.1.2. Reference Laboratories

12.1.2.1. Market Revenue and Forecast (2021-2032)

12.1.3. Contract Research Organizations

12.1.3.1. Market Revenue and Forecast (2021-2032)

12.1.4. Other End Users

12.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 13. Global Companion Diagnostics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Indication (2021-2032)

13.1.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.1.3. Market Revenue and Forecast, by Technology (2021-2032)

13.1.4. Market Revenue and Forecast, by Indication (2021-2032)

13.1.5. Market Revenue and Forecast, by End-User (2021-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Indication (2021-2032)

13.1.6.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.1.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.1.6.4. Market Revenue and Forecast, by Indication (2021-2032)

13.1.6.5. Market Revenue and Forecast, by End-User (2021-2032) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Indication (2021-2032)

13.1.7.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.1.7.3. Market Revenue and Forecast, by Technology (2021-2032)

13.1.7.4. Market Revenue and Forecast, by Indication (2021-2032)

13.1.7.5. Market Revenue and Forecast, by End-User (2021-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Indication (2021-2032)

13.2.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.2.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.4. Market Revenue and Forecast, by Indication (2021-2032) 

13.2.5. Market Revenue and Forecast, by End-User (2021-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Indication (2021-2032)

13.2.6.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.2.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.7. Market Revenue and Forecast, by Indication (2021-2032) 

13.2.8. Market Revenue and Forecast, by End-User (2021-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Indication (2021-2032)

13.2.9.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.2.9.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.10. Market Revenue and Forecast, by Indication (2021-2032)

13.2.11. Market Revenue and Forecast, by End-User (2021-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Indication (2021-2032)

13.2.12.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.2.12.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.12.4. Market Revenue and Forecast, by Indication (2021-2032)

13.2.13. Market Revenue and Forecast, by End-User (2021-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Indication (2021-2032)

13.2.14.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.2.14.3. Market Revenue and Forecast, by Technology (2021-2032)

13.2.14.4. Market Revenue and Forecast, by Indication (2021-2032)

13.2.15. Market Revenue and Forecast, by End-User (2021-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Indication (2021-2032)

13.3.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.3.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.4. Market Revenue and Forecast, by Indication (2021-2032)

13.3.5. Market Revenue and Forecast, by End-User (2021-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Indication (2021-2032)

13.3.6.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.3.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.6.4. Market Revenue and Forecast, by Indication (2021-2032)

13.3.7. Market Revenue and Forecast, by End-User (2021-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Indication (2021-2032)

13.3.8.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.3.8.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.8.4. Market Revenue and Forecast, by Indication (2021-2032)

13.3.9. Market Revenue and Forecast, by End-User (2021-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Indication (2021-2032)

13.3.10.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.3.10.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.10.4. Market Revenue and Forecast, by Indication (2021-2032)

13.3.10.5. Market Revenue and Forecast, by End-User (2021-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Indication (2021-2032)

13.3.11.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.3.11.3. Market Revenue and Forecast, by Technology (2021-2032)

13.3.11.4. Market Revenue and Forecast, by Indication (2021-2032)

13.3.11.5. Market Revenue and Forecast, by End-User (2021-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Indication (2021-2032)

13.4.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.4.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.4. Market Revenue and Forecast, by Indication (2021-2032)

13.4.5. Market Revenue and Forecast, by End-User (2021-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Indication (2021-2032)

13.4.6.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.4.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.6.4. Market Revenue and Forecast, by Indication (2021-2032)

13.4.7. Market Revenue and Forecast, by End-User (2021-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Indication (2021-2032)

13.4.8.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.4.8.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.8.4. Market Revenue and Forecast, by Indication (2021-2032)

13.4.9. Market Revenue and Forecast, by End-User (2021-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Indication (2021-2032)

13.4.10.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.4.10.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.10.4. Market Revenue and Forecast, by Indication (2021-2032)

13.4.10.5. Market Revenue and Forecast, by End-User (2021-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Indication (2021-2032)

13.4.11.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.4.11.3. Market Revenue and Forecast, by Technology (2021-2032)

13.4.11.4. Market Revenue and Forecast, by Indication (2021-2032)

13.4.11.5. Market Revenue and Forecast, by End-User (2021-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Indication (2021-2032)

13.5.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.5.3. Market Revenue and Forecast, by Technology (2021-2032)

13.5.4. Market Revenue and Forecast, by Indication (2021-2032)

13.5.5. Market Revenue and Forecast, by End-User (2021-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Indication (2021-2032)

13.5.6.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.5.6.3. Market Revenue and Forecast, by Technology (2021-2032)

13.5.6.4. Market Revenue and Forecast, by Indication (2021-2032)

13.5.7. Market Revenue and Forecast, by End-User (2021-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Indication (2021-2032)

13.5.8.2. Market Revenue and Forecast, by Product & Service (2021-2032)

13.5.8.3. Market Revenue and Forecast, by Technology (2021-2032)

13.5.8.4. Market Revenue and Forecast, by Indication (2021-2032)

13.5.8.5. Market Revenue and Forecast, by End-User (2021-2032)

Chapter 14. Company Profiles

14.1. F. Hoffmann-La Roche Ltd. (Switzerland)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies, Inc. (US)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Qiagen N.V. (Germany)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Thermo Fisher Scientific, Inc. (US)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Abbott Laboratories, Inc. (US)

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms